Organogenesis Holdings (ORGO) Share-based Compensation Growth (1y) (2019 - 2026)
Organogenesis Holdings (ORGO) Share-based Compensation Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 26.47% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 47.06% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 6.60% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -133.31% |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 8.33% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 40.00% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 59.27% |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | -24.33% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 48.29% |
| 10 | Organogenesis Holdings | 304.80 Mn | 212.70 Mn | 11.46 Mn | 7.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.99% |
| Dec 31, 2025 | 49.57% |
| Sep 30, 2025 | 13.02% |
| Jun 30, 2025 | -1.01% |
| Mar 31, 2025 | 39.88% |
| Dec 31, 2024 | 22.19% |
| Sep 30, 2024 | 12.21% |
| Jun 30, 2024 | 11.70% |
| Mar 31, 2024 | 25.76% |
| Dec 31, 2023 | 27.55% |
| Sep 30, 2023 | 42.01% |
| Jun 30, 2023 | 35.87% |
| Mar 31, 2023 | 46.89% |
| Dec 31, 2022 | 71.28% |
| Sep 30, 2022 | 63.50% |
| Jun 30, 2022 | 62.38% |
| Mar 31, 2022 | 86.68% |
| Dec 31, 2021 | 117.91% |
| Sep 30, 2021 | 114.20% |
| Jun 30, 2021 | 122.17% |